Tag Archives: COPD

Indacaterol/Glycopyrronium Improves Regional Ventilation in COPD

January 31, 2019 Share this content: Significant improvements were reported in total and regional pulmonary microvascular blood flow. In patients with moderate to severe chronic obstructive pulmonary disease (COPD), pharmacologic intervention with indacaterol/glycopyrronium (IND/GLY) is associated with improvements in regional ventilation and pulmonary microvascular blood flow (PMBF), according to findings published in the American Journal… Read More »

Blood Eosinophilia-Targeted COPD Treatment: LABA-ICS vs LAMAs

December 06, 2018 Share this content: The incidence of pneumonia rose with initiation of LABA-ICS, which was similar across all eosinophil concentrations. Blood eosinophil concentrations could be used to target patients with chronic obstructive pulmonary disease (COPD) who are likely to respond to initial long-acting bronchodilator therapy. This, in turn, may help clinicians decide between… Read More »

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ: MYL) (“Mylan”) today announced that the U.S. Food and Drug Administration (FDA) has approved the  New Drug Application (NDA) for… Read More »